Denali Therapeutics Inc. (DNLI) Tops Q2 EPS by 8c

Denali Therapeutics Inc. (NASDAQ: DNLI) reported Q2 EPS of ($0.59), $0.08 better than the analyst estimate of ($0.67).

For earnings history and earnings-related data on Denali Therapeutics Inc. (DNLI) click here.

You May Also Be Interested In

• Eos Energy Enterprises (EOSE) PT Lowered to $5 at B.Riley
• Jernigan Capital (JCAP) Tops Q2 EPS by 5c
• Tenon Medical (TNON) Misses Q2 EPS by 395c